Search 
Saturday, July 05, 2008 ..:: Clinical Trials ::.. Register  Login
 Clinical Trials Minimize

 Print   
 Search Trials Minimize

 Print   
 Archives Minimize
Study Number:

Search


  
 Thoracic Minimize
Category: Thoracic Created: 1/2/2007 11:44 AM
Thoracic

Lung (100671)
Sponsor: SWOG (S9925)

By Thoracic on 7/5/2008 10:00 AM
Lung Cancer Specimen Repository Protocol, Ancillary

HIPAA Authorization - MUSC
Informed Consent - Tissue
Protocol
More...

Lung (100857)
Sponsor: DOD (100857)

By Thoracic on 7/5/2008 10:00 AM
Development and Testing of Multivariate Statisticial Prediction Model of Malignancy Potential of Small (<3 cm) Pulmonary Nodules

None Available
More...

Lung-NSC (100959)
Sponsor: ACRIN (6668)

By Thoracic on 7/5/2008 10:00 AM
Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-NSC (101115)
Sponsor: RTOG (0229)

By Thoracic on 7/5/2008 10:00 AM
A Phase II Trial Of Neoadjuvant Therapy With Concurrent Chemotherapy And High Dose Radiotherapy Followed By Surgical Resection And Consolidative Therapy For Locally Advanced Non-Small Cell Lung Carcinoma

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-NSC (101135)
Sponsor: CTSU/ECOG (E1505)

By Thoracic on 7/5/2008 10:00 AM
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC )

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-NSC (101173)
Sponsor: CTSU/CALGB (140503)

By Thoracic on 7/5/2008 10:00 AM
A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (< 2cm) Peripheral Non-Small Cell Lung Cancer.

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-SC (101149)
Sponsor: SWOG (0635)

By Thoracic on 7/5/2008 10:00 AM
A Phase II Trial of the Combination of OSI-774(Erlotinib; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) In Stage IIIB and IV Bronchioloalveloar Carcinoma (BAC) and Adenocarcinoma with BAC features (AdenoBAC)

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-SC (101150)
Sponsor: SWOG (0636)

By Thoracic on 7/5/2008 10:00 AM
Phase II Trial of the Combination of OSI-774 (Erlotinib; NSC-718781) and Bevacizumab (Rhumab VEGF; NSC-704865) In Never Smokers With Stage IIIB and IV Primary Lung Adenocarcinomas

HIPAA Authorization
Informed Consent
Protocol
More...

Lung-SC (101153)
Sponsor: ACRIN (6678)

By Thoracic on 7/5/2008 10:00 AM
FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-small Cell Lung Cancer

None Available
More...

Lung-SC (101224)
Sponsor: American Cancer Society (101224)

By Thoracic on 7/5/2008 10:00 AM
Race and Patient-Related Factors Underlying Willingness to Undergo Surgery for Lung Cancer.

None Available
More...

Lymphoma (101133)
Sponsor: Fujirebio Diagnostics, Inc. (FDI-02)

By Thoracic on 7/5/2008 10:00 AM
Evaluation of Multiple Biomarkers in Serum and Pleural Fluid to Estimate the Probability of Cancer in Patients Presenting with a Pleural Effusion

None Available
More...

NSCLC (100983)
Sponsor: ACOSOG (Z4032)

By Thoracic on 7/5/2008 10:00 AM
A Randomized Phase III Study of Sublobal Resection versus Sublobar Resection Plus Brachytherapy in High Risk Patients with Non-Small Cell Lung Cancer, 3 cm or Smaller

HIPAA Authorization
Informed Consent - Intervention
Protocol
More...


 Print   
Copyright 2007 by Hollings Cancer Center   Terms Of Use  Privacy Statement